(2S,3S,4R,5R)-5-[6-氨基-2-(2-苯基乙基氨基)嘌呤-9-基]-N-乙基-3,4-二羟基四氢呋喃-2-甲酰胺 | 120225-53-8

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘌呤核苷
• 中文名称: (2S,3S,4R,5R)-5-[6-氨基-2-(2-苯基乙基氨基)嘌呤-9-基]-N-乙基-3,4-二羟基四氢呋喃-2-甲酰胺
• 英文名称: CGS 21577
• 英文别名: 2-(2-phenyl)ethylaminoadenosine-5'-N-ethylcarboxamide；2-Phenethylamino-5'-N-ethylcarboxamidoadenosine；(2S,3S,4R,5R)-5-[6-amino-2-(2-phenylethylamino)purin-9-yl]-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide
• CAS: 120225-53-8
• 化学式: C₂₀H₂₅N₇O₄
• 分子量: 427.463
• InChiKey: UQERKZWKUCVXID-QCUYGVNKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  31
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  160
• 氢给体数：
  5
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  2-氯-2,3-o-异亚丙基腺苷酸-5-n-乙基羧酰胺 在 盐酸 作用下， 反应 4.0h， 生成 (2S,3S,4R,5R)-5-[6-氨基-2-(2-苯基乙基氨基)嘌呤-9-基]-N-乙基-3,4-二羟基四氢呋喃-2-甲酰胺
  参考文献：
  名称：

  2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligands

  摘要：

  The synthesis and receptor-binding profiles at adenosine receptor subtypes for a series of 2-(arylalkylamino)-adenosin-5'-uronamides is described. Halogenated 2-phenethylamino analogues such as 3e show greater than 200-fold selectivity for the A2 receptor subtype on the basis of rat brain receptor binding. The general structure-activity relationship of this series of compounds is discussed both in terms of potency at A2 receptors as well as receptor subtype selectivity. It is possible to introduce a hydrophilic carboxyalkyl substituent to this series such as in CGS 21680A (3h) and still retain good potency and selectivity for A2 receptors. In addition, functional data in a perfused working rat heart model shows that these compounds possess full agonist properties at A2 receptors with 3h having a greater than 1500-fold separation between A2 (coronary vasodilatory) and A1 (negative chronotropic) receptor mediated events.

  DOI：

  10.1021/jm00169a015

文献信息

• Synthesis and Pharmacological Evaluation of Dual Acting Antioxidant A_2A Adenosine Receptor Agonists
  作者：Nicholas E. Hausler、Shane M. Devine、Fiona M. McRobb、Lyndon Warfe、Colin W. Pouton、John M. Haynes、Steven E. Bottle、Paul J. White、Peter J. Scammells

  DOI：10.1021/jm300206u

  日期：2012.4.12

  A series of adenosine-5′-N-alkylcarboxamides and N6-(2,2-diphenylethyl)adenosine-5′-N-alkylcarboxamides bearing antioxidant moieties in the 2-position were synthesized from the versatile intermediate, O6-(benzotriazol-1-yl)-2-fluoro-2′,3′-O-isopropylideneinosine-5′-N-alkylcarboxamide (1). These compounds were evaluated as A2A adenosine receptor (A2AR) agonists in a cAMP accumulation assay, and a number

  从多用途中间体O 6-（苯并三唑）合成了一系列在2-位带有抗氧化剂部分的腺苷-5' - N-烷基羧酰胺和N 6-（2,2-二苯乙基）腺苷-5' - N-烷基羧酰胺-1-基）-2-氟-2'，3' - O-异丙叉亚氨酸-5' - N-烷基羧酰胺（1）。这些化合物被评估为A 2A腺苷受体（A 2AR）在cAMP积累测定中的激动剂，并且鉴定了许多有效的和选择性的激动剂。在缺血性损伤细胞存活率测定和活性氧（ROS）产生测定中进一步评估了其中的三种化合物，其中15b和15c显示减少了ROS活性和由于缺血引起的细胞死亡。
• Linear and convergent approaches to 2-substituted adenosine-5′-N-alkylcarboxamides
  作者：Richard C. Foitzik、Shane M. Devine、Nicholas E. Hausler、Peter J. Scammells

  DOI：10.1016/j.tet.2009.08.057

  日期：2009.10

  Herein we report both linear and convergent pathways for the preparation of 2-alkynyl substituted adenosine-5'-N-ethylcarboxamides via the versatile synthetic intermediate, 2-iodoadenosine-5'-N-ethylcarboxamide (13). The linear approach afforded 13 in an overall yield of 30% from guanosine over eight synthetic steps. The convergent approach was shorter, but proceeded in lower yield (five steps, 20% yield). Both approaches compare favourably with previously reported syntheses of 13, which has been prepared in 15% yield from guanosine over nine steps. 2-Iodoadenosine-5'-N-ethylcarboxamide (13) was subsequently converted to HENECA (2) and PHPNECA (3) to exemplify the utility of this approach for the preparation of potent A(2A) adenosine receptor agonists. The linear approach was also amenable to the synthesis of 2-fluoropurine ribosides, which were subsequently elaborated into 2-alkylaminoadenosine-5'-N-ethylcarboxamides. Furthermore, both of these synthetic approaches are readily amenable to the synthesis of adenosine analogues with varied 2-, 6- and 5'-substitution patterns. (c) 2009 Elsevier Ltd. All rights reserved.
• HUTCHISON, ALAN J.;WILLIAMS, MICHAEL;JESUS, REYNALDA DE;RINA, YOKOYAMA;OE+, J. MED. CHEM., 33,(1990) N, C. 1919-1924
  作者：HUTCHISON, ALAN J.、WILLIAMS, MICHAEL、JESUS, REYNALDA DE、RINA, YOKOYAMA、OE+

  DOI：——

  日期：——
• 2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligands
  作者：Alan J. Hutchison、Michael Williams、Reynalda De Jesus、Rina Yokoyama、Howard H. Oei、Geetha R. Ghai、Randy L. Webb、Harry C. Zoganas、George A. Stone、Michael F. Jarvis

  DOI：10.1021/jm00169a015

  日期：1990.7

  The synthesis and receptor-binding profiles at adenosine receptor subtypes for a series of 2-(arylalkylamino)-adenosin-5'-uronamides is described. Halogenated 2-phenethylamino analogues such as 3e show greater than 200-fold selectivity for the A2 receptor subtype on the basis of rat brain receptor binding. The general structure-activity relationship of this series of compounds is discussed both in terms of potency at A2 receptors as well as receptor subtype selectivity. It is possible to introduce a hydrophilic carboxyalkyl substituent to this series such as in CGS 21680A (3h) and still retain good potency and selectivity for A2 receptors. In addition, functional data in a perfused working rat heart model shows that these compounds possess full agonist properties at A2 receptors with 3h having a greater than 1500-fold separation between A2 (coronary vasodilatory) and A1 (negative chronotropic) receptor mediated events.